Incidence of Kidney Disease

RECENT NEWS
MedPage Today  Aug 10  Comment 
(MedPage Today) -- GFR impairment rises but albuminuria falls
Motley Fool  Aug 1  Comment 
A supply problem for Auryxia forced the biopharma to pull its full-year forecast.
MarketWatch  Aug 1  Comment 
Keryx Biopharmaceuticals Inc. shares were halted in pre-market trade Monday and the company said its kidney disease drug Auryxia wouldn't be available through about the fourth quarter, due to a production-related issue. The supply interruption,...
FierceBiotech  Jul 25  Comment 
Tricida raises $55M, to get kidney disease data this year badams Mon, 07/25/2016 - 08:46
Motley Fool  Jun 22  Comment 
The company's new treatment for a condition common in chronic kidney disease patients will be available soon, but investors might not want to rush in and buy shares.
FierceBiotech  Jun 21  Comment 
Opko up on first FDA approval in chronic kidney disease associated indication slawrence Tue, 06/21/2016 - 08:27
MedPage Today  Jun 20  Comment 
(MedPage Today) -- Deficiency associated with a number of disease-related factors
FierceBiotech  Jun 20  Comment 
U.K.’s Mironid closes $6.2M Series A for cancer, kidney disease projects badams Mon, 06/20/2016 - 04:42
MedPage Today  Jun 14  Comment 
(MedPage Today) -- Type 2 diabetes drug already shows cardiovascular benefits




 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki